Treatment Algorithm for Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome Derived from a Canadian National Survey and Needs Assessment on Choices of Therapeutic Agents
Background. Chronic idiopathic constipation (CIC) and constipation-predominant irritable bowel syndrome (IBS-C) are common functional lower gastrointestinal disorders that impair patients’ quality of life. In a national survey, we aimed to evaluate (1) Canadian physician practice patterns in the uti...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2017-01-01
|
| Series: | Canadian Journal of Gastroenterology and Hepatology |
| Online Access: | http://dx.doi.org/10.1155/2017/8612189 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841524716042452992 |
|---|---|
| author | Yvonne Tse David Armstrong Christopher N. Andrews Alain Bitton Brian Bressler John Marshall Louis W. C. Liu |
| author_facet | Yvonne Tse David Armstrong Christopher N. Andrews Alain Bitton Brian Bressler John Marshall Louis W. C. Liu |
| author_sort | Yvonne Tse |
| collection | DOAJ |
| description | Background. Chronic idiopathic constipation (CIC) and constipation-predominant irritable bowel syndrome (IBS-C) are common functional lower gastrointestinal disorders that impair patients’ quality of life. In a national survey, we aimed to evaluate (1) Canadian physician practice patterns in the utilization of therapeutic agents listed in the new ACG and AGA guidelines; (2) physicians satisfaction with these agents for their CIC and IBS-C patients; and (3) the usefulness of these new guidelines in their clinical practice. Methods. A 9-item questionnaire was sent to 350 Canadian specialists to evaluate their clinical practice for the management of CIC and IBS-C. Results. The response rate to the survey was 16% (n=55). Almost all (96%) respondents followed a standard, stepwise approach for management while they believed that only 24% of referring physicians followed the same approach. Respondents found guanylyl cyclase C (GCC) agonist most satisfying when treating their patients. Among the 69% of respondents who were aware of published guidelines, only 50% found them helpful in prioritizing treatment choices and 69% of respondents indicated that a treatment algorithm, applicable to Canadian practice, would be valuable. Conclusion. Based on this needs assessment, a treatment algorithm was developed to provide clinical guidance in the management of IBS-C and CIC in Canada. |
| format | Article |
| id | doaj-art-42bfe82d6f0f48d4aad9a17781f75bbd |
| institution | Kabale University |
| issn | 2291-2789 2291-2797 |
| language | English |
| publishDate | 2017-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Gastroenterology and Hepatology |
| spelling | doaj-art-42bfe82d6f0f48d4aad9a17781f75bbd2025-02-03T05:47:33ZengWileyCanadian Journal of Gastroenterology and Hepatology2291-27892291-27972017-01-01201710.1155/2017/86121898612189Treatment Algorithm for Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome Derived from a Canadian National Survey and Needs Assessment on Choices of Therapeutic AgentsYvonne Tse0David Armstrong1Christopher N. Andrews2Alain Bitton3Brian Bressler4John Marshall5Louis W. C. Liu6University of Toronto, Toronto, ON, CanadaMcMaster University, Hamilton, ON, CanadaUniversity of Calgary, Calgary, AB, CanadaMcGill University, Montreal, QC, CanadaUniversity of British Columbia, Vancouver, BC, CanadaMcMaster University, Hamilton, ON, CanadaUniversity of Toronto, Toronto, ON, CanadaBackground. Chronic idiopathic constipation (CIC) and constipation-predominant irritable bowel syndrome (IBS-C) are common functional lower gastrointestinal disorders that impair patients’ quality of life. In a national survey, we aimed to evaluate (1) Canadian physician practice patterns in the utilization of therapeutic agents listed in the new ACG and AGA guidelines; (2) physicians satisfaction with these agents for their CIC and IBS-C patients; and (3) the usefulness of these new guidelines in their clinical practice. Methods. A 9-item questionnaire was sent to 350 Canadian specialists to evaluate their clinical practice for the management of CIC and IBS-C. Results. The response rate to the survey was 16% (n=55). Almost all (96%) respondents followed a standard, stepwise approach for management while they believed that only 24% of referring physicians followed the same approach. Respondents found guanylyl cyclase C (GCC) agonist most satisfying when treating their patients. Among the 69% of respondents who were aware of published guidelines, only 50% found them helpful in prioritizing treatment choices and 69% of respondents indicated that a treatment algorithm, applicable to Canadian practice, would be valuable. Conclusion. Based on this needs assessment, a treatment algorithm was developed to provide clinical guidance in the management of IBS-C and CIC in Canada.http://dx.doi.org/10.1155/2017/8612189 |
| spellingShingle | Yvonne Tse David Armstrong Christopher N. Andrews Alain Bitton Brian Bressler John Marshall Louis W. C. Liu Treatment Algorithm for Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome Derived from a Canadian National Survey and Needs Assessment on Choices of Therapeutic Agents Canadian Journal of Gastroenterology and Hepatology |
| title | Treatment Algorithm for Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome Derived from a Canadian National Survey and Needs Assessment on Choices of Therapeutic Agents |
| title_full | Treatment Algorithm for Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome Derived from a Canadian National Survey and Needs Assessment on Choices of Therapeutic Agents |
| title_fullStr | Treatment Algorithm for Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome Derived from a Canadian National Survey and Needs Assessment on Choices of Therapeutic Agents |
| title_full_unstemmed | Treatment Algorithm for Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome Derived from a Canadian National Survey and Needs Assessment on Choices of Therapeutic Agents |
| title_short | Treatment Algorithm for Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome Derived from a Canadian National Survey and Needs Assessment on Choices of Therapeutic Agents |
| title_sort | treatment algorithm for chronic idiopathic constipation and constipation predominant irritable bowel syndrome derived from a canadian national survey and needs assessment on choices of therapeutic agents |
| url | http://dx.doi.org/10.1155/2017/8612189 |
| work_keys_str_mv | AT yvonnetse treatmentalgorithmforchronicidiopathicconstipationandconstipationpredominantirritablebowelsyndromederivedfromacanadiannationalsurveyandneedsassessmentonchoicesoftherapeuticagents AT davidarmstrong treatmentalgorithmforchronicidiopathicconstipationandconstipationpredominantirritablebowelsyndromederivedfromacanadiannationalsurveyandneedsassessmentonchoicesoftherapeuticagents AT christophernandrews treatmentalgorithmforchronicidiopathicconstipationandconstipationpredominantirritablebowelsyndromederivedfromacanadiannationalsurveyandneedsassessmentonchoicesoftherapeuticagents AT alainbitton treatmentalgorithmforchronicidiopathicconstipationandconstipationpredominantirritablebowelsyndromederivedfromacanadiannationalsurveyandneedsassessmentonchoicesoftherapeuticagents AT brianbressler treatmentalgorithmforchronicidiopathicconstipationandconstipationpredominantirritablebowelsyndromederivedfromacanadiannationalsurveyandneedsassessmentonchoicesoftherapeuticagents AT johnmarshall treatmentalgorithmforchronicidiopathicconstipationandconstipationpredominantirritablebowelsyndromederivedfromacanadiannationalsurveyandneedsassessmentonchoicesoftherapeuticagents AT louiswcliu treatmentalgorithmforchronicidiopathicconstipationandconstipationpredominantirritablebowelsyndromederivedfromacanadiannationalsurveyandneedsassessmentonchoicesoftherapeuticagents |